51
Participants
Start Date
April 30, 2014
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
Measurement of drug (Adalimumab/Infliximab)
Measurement of drug (adalimumab/infliximab) and ADAs in the presence of drug.
Intensify treatment with the existing drug
Intensify treatment with the existing drug and if this fails empirically switch to another TNF antagonist
Rocky Mountain Gastroenterology Associates, Denver
Collaborators (1)
Prometheus Laboratories
INDUSTRY
University of Western Ontario, Canada
OTHER